Search for:

Minh Ha Vu

Minh Ha specializes in providing the regulatory advice, tender advice and compliance advice in the healthcare and pharmaceutical industry, with particular focus on drugs, medical devices, biological products, etc. She leads the product registration team in Vietnam, specializing in the registration of drugs, health supplements, food and beverage, cosmetics and medical devices. Prior to joining Baker McKenzie, Minh Ha worked as a legal counsel for a French pharmaceutical group in Vietnam.

On 9 January 2023, the National Assembly of Vietnam issued Law No. 15/2023/QH15 on Medical Examination and Treatment, which sets out a significant number of new regulations on healthcare and medical activities. The New Law will take effect on 1 January 2024, replacing the current Law No. 40/2009/QH12 on Medical Examination and Treatment dated 23 November 2009.

In brief The Ministry of Health (“MOH”) has published a draft circular dated December 2020, proposing the publication of lists of substances whose usage is banned in the production and trading of health supplements (“Draft Circular”). This Draft Circular is expected to come into effect in 2021, with no indication…